Tompkins Financial Corp’s Eli Lilly & Co Position
Does Tompkins Financial Corp own Eli Lilly & Co (LLY)? Yes — 28.2K shares worth $26M (+2.06% of its 13F portfolio) as of Q1 2026, down from 29.1K shares the prior filed quarter.
Position Value
$26M
Q1 2026
Shares
28.2K
% of Portfolio
+2.06%
Quarters Held
29
currently held
Position History LLY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 28.2K | $26M | +2.06% |
| Q4 2025 | 29.1K | $31M | +2.43% |
| Q3 2025 | 30.3K | $23M | +1.93% |
| Q2 2025 | 30.9K | $24M | +2.22% |
| Q1 2025 | 33.1K | $27M | +2.61% |
| Q4 2024 | 33.3K | $26M | +2.39% |
| Q3 2024 | 31.0K | $27M | +2.63% |
| Q2 2024 | 31.4K | $28M | +2.98% |
| Q1 2024 | 30.9K | $24M | +2.71% |
| Q4 2023 | 32.0K | $19M | +2.26% |
| Q3 2023 | 34.8K | $19M | +2.94% |
| Q2 2023 | 33.6K | $16M | +2.47% |
| Q1 2023 | 36.6K | $13M | +2.05% |
| Q4 2022 | 37.4K | $13,679 | +2.16% |
| Q3 2022 | 39.5K | $13M | +2.16% |
| Q2 2022 | 40.4K | $13M | +2.10% |
| Q1 2022 | 41.0K | $12M | +1.66% |
| Q4 2021 | 40.7K | $11M | +1.99% |
| Q3 2021 | 41.4K | $10M | +1.75% |
| Q2 2021 | 43.7K | $8M | +1.38% |
| Q4 2020 | 43.6K | $7M | +1.32% |
| Q3 2020 | 41.2K | $6M | +1.17% |
| Q2 2020 | 41.1K | $7M | +1.42% |
| Q1 2020 | 40.1K | $6M | +1.28% |
| Q4 2019 | 41.7K | $5M | +1.00% |
| Q3 2019 | 37.0K | $4M | +0.84% |
| Q2 2019 | 36.9K | $4M | +0.82% |
| Q1 2019 | 36.5K | $5M | +0.90% |
| Q4 2018 | 36.2K | $4M | +0.92% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Tompkins Financial Corp’s full portfolio or all institutional holders of LLY.